Emory Saint Joseph’s Hospital, Atlanta, USA, is improving treatment for stroke patients with the launch of a Telestroke programme, which allows neurologists to remotely evaluate patients around the clock through real-time conferencing with a Telerobot monitor.
Monteris Medical has announced recent data demonstrating that newly diagnosed brain tumour patients undergoing procedures with the NeuroBlate system, a minimally invasive robotic laser thermotherapy tool, experienced improved outcomes. These findings, along with a separate case study presentation highlighting the first successful ablation of the hippocampus and amygdala using a directional laser, were presented during the 2015 Congress of Neurological Surgeons Annual Scientific Meeting (26–30 September, New Orleans, USA).
One of the newest devices to surface for the treatment of acute ischaemic stroke is the EmboTrap from Neuravi. At the World Live Neurovascular Course (WLNC; 8–10 June, Chicago, USA) Osama Zaidat (Medical College of Wisconsin, Milwaukee, USA) and Tommy Andersson (AZ Groeninge, Kortrijk, Belgium and Karolinska University Hospital, Stockholm, Sweden) introduced the device and presented the results of the first 25 cases performed by Andersson and the team at Karolinska in Sweden.
In the first study to be published reporting on endovascular aneurysm treatment with the p64 flow modulation device (Phenox), Francesco Briganti and colleagues have found that the device provides a safe procedure with no technical complications.
While the traditional unsheathing technique for the deployment of stent retrievers has proved successful in clinical use, in their experience, Raul Gomes Nogueira (Emory University School of Medicine, Atlanta, USA) and colleagues have developed a new technique for the deployment of the Trevo ProVue stent retriever (Stryker Neurovascular) that they have found produces better results than the traditional technique. At the Society of NeuroInterventional Surgery 12th Annual Meeting (SNIS; 27–30 July, San Francisco, USA), Nogueira presented the Push & Fluff technique and he now speaks to NeuroNews about how it was developed and the results they have seen so far.
InspireMD announced the full market launch of the CGuard Embolic Prevention System for the treatment of carotid artery disease by its strategic distribution partner, Penumbra, at the CIRSE Annual Congress (26–30 September, Lisbon, Portugal). Penumbra leverages its direct European commercialisation team to launch CGuard distributed by Penumbra.
Neuravi has announced commercial availability of the company’s EmboTrap Revascularisation Device for the treatment of acute ischaemic stroke in Europe. The device will be marketed through the sales and distribution network the company has established in Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Spain, Sweden and Switzerland.
Codman Neuro has developed a new MRI-resistant programmable valve with eight different pressure settings, including a ‘virtual off’ setting, for the treatment of hydrocephalus. The announcement was made here at the Seventh Meeting of the International Society for Hydrocephalus and CSF Disorders. Codman Neuro is a global leader in neurosurgery and part of DePuy Synthes Companies of Johnson & Johnson.
Robert Levy, director of the Marcus Neuroscience Institute (MNI) at Boca Raton Regional Hospital, USA, is the first physician in the state of Florida to use the Senza spinal cord stimulation (SCS) system as a method to treat patients with chronic back and leg pain. The Senza SCS system, developed by Nevro, is a spinal cord stimulator that has demonstrated superior results as compared to standard stimulation systems, with patients achieving approximately a 50% greater improvement in pain score than those with traditional SCS therapy.
Medtronic plc has announced that it has acquired Medina Medical, a Menlo Park, California, USA-based and privately-held medical device company focused on commercialising state-of-the-art treatments for vascular abnormalities of the brain including cerebral aneurysms.
Stryker Neurovascular has announced that it has received the CE mark for the Neuroform Atlas Stent System. The Neuroform Atlas Stent is a new 4th-generation adjunctive stent, pushing forward the adjunctive stent landscape which previously included woven, closed-cell, and open-celled stents. According to Stryker Neurovascular, the Neuroform Atlas Stent features an innovative adaptive cell architecture that is designed to optimise conformability and stability when treating wide-neck intracranial aneurysms. Physicians can deliver all sizes of the Neuroform Atlas Stent, from 3.0mm up to 4.5mm in diameter, through a low-profile Excelsior SL-10 microcatheter.
In a 10-site European study reported in the American Journal of Neuroradiology, the safety and efficiency of the single-layer Woven EndoBridge (WEB-SL) device was found to be comparable to that of the older double-layer device. According to the authors, this study is the largest WEB study undertaken to date where WEB-SL devices were used to treat aneurysms that would normally be considered difficult to treat with traditional endovascular approaches.
In a multicentre study, the Aperio thrombectomy device (Acandis) demonstrated safety and efficacy as a tool for reopening occluded cerebral arteries in the setting of an acute ischaemic stroke.
Doctors at Univehe brain of a 71-year-old female patient. Doctors at University Hospital La Timone, Marseille, France, have used their new Leksell Gamma Knife Icon system to treat a metastasis in the brain of a 71-year-old female patient.
During a stroke, slightly more than half of patients use emergency medical services to get to the hospital, with white women the most likely, and Hispanic men the least likely to use emergency transport, according to new research in Journal of the American Heart Association.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos